Lianmei Zhang

660 total citations
26 papers, 477 citations indexed

About

Lianmei Zhang is a scholar working on Molecular Biology, Oncology and Infectious Diseases. According to data from OpenAlex, Lianmei Zhang has authored 26 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Oncology and 4 papers in Infectious Diseases. Recurrent topics in Lianmei Zhang's work include COVID-19 Clinical Research Studies (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Lianmei Zhang is often cited by papers focused on COVID-19 Clinical Research Studies (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Lianmei Zhang collaborates with scholars based in China, United States and India. Lianmei Zhang's co-authors include Junjiang Fu, Jiewen Fu, Chunli Wei, Hanchun Chen, Xiaoyan Liu, Luquan Yang, Manman Yang, Jingliang Cheng, Xiuli Xiao and Jiayue He and has published in prestigious journals such as Frontiers in Immunology, Molecules and European Journal of Nuclear Medicine and Molecular Imaging.

In The Last Decade

Lianmei Zhang

25 papers receiving 468 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lianmei Zhang China	11	184	138	108	53	51	26	477
Vahideh Keyvani Iran	10	185 1.0×	98 0.7×	86 0.8×	76 1.4×	22 0.4×	19	451
Anshika Srivastava India	15	266 1.4×	72 0.5×	120 1.1×	81 1.5×	10 0.2×	37	632
Rong Liang China	13	107 0.6×	89 0.6×	27 0.3×	83 1.6×	30 0.6×	42	437
Amin Daei Sorkhabi Iran	10	92 0.5×	161 1.2×	49 0.5×	118 2.2×	16 0.3×	22	374
J Górski United States	12	156 0.8×	111 0.8×	20 0.2×	66 1.2×	24 0.5×	29	601
Aila Sarkesh Iran	10	74 0.4×	162 1.2×	49 0.5×	114 2.2×	16 0.3×	20	361
Kevin Baßler Germany	12	243 1.3×	67 0.5×	144 1.3×	275 5.2×	10 0.2×	21	669
Yan Zhan China	10	137 0.7×	57 0.4×	217 2.0×	97 1.8×	11 0.2×	25	475
Zhaonian Hao China	6	138 0.8×	130 0.9×	142 1.3×	109 2.1×	5 0.1×	12	444

Countries citing papers authored by Lianmei Zhang

Since Specialization

Citations

This map shows the geographic impact of Lianmei Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lianmei Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lianmei Zhang more than expected).

Fields of papers citing papers by Lianmei Zhang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lianmei Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lianmei Zhang. The network helps show where Lianmei Zhang may publish in the future.

Co-authorship network of co-authors of Lianmei Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Lianmei Zhang. A scholar is included among the top collaborators of Lianmei Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lianmei Zhang. Lianmei Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Jinglin, Xin Meng, Xuedong Han, et al.. (2025). Development and clinical evaluation of [68Ga]Ga-NODAGA-ADAPT6 as a novel HER2-targeted PET radiotracer for breast cancer imaging and treatment monitoring. European Journal of Nuclear Medicine and Molecular Imaging. 52(11). 4078–4091.

Zhang, Lianmei, et al.. (2024). Dexamethasone promotes renal fibrosis by upregulating ILT4 expression in myeloid‐derived suppressor cells. Journal of Cellular and Molecular Medicine. 28(9). e18310–e18310. 1 indexed citations

Feng, Lei, et al.. (2023). Gabor-YOLONet: A lightweight and efficient detection network for low-voltage power lines from unmanned aerial vehicle images. Frontiers in Energy Research. 10. 7 indexed citations

Fu, Jiewen, Wenqian Zhang, Lianmei Zhang, et al.. (2023). Effect of DPP4/CD26 expression on SARS‑CoV‑2 susceptibility, immune response, adenosine (derivatives m⁶₂A and CD) regulations on patients with cancer and healthy individuals. International Journal of Oncology. 62(3). 66–72. 13 indexed citations

Zhang, Lianmei, Yaning Zhu, Xiaoyan Liu, et al.. (2023). CTSL, a prognostic marker of breast cancer, that promotes proliferation, migration, and invasion in cells in triple-negative breast cancer. Frontiers in Oncology. 13. 1158087–1158087. 8 indexed citations

Fu, Jiewen, Jiayue He, Lianmei Zhang, et al.. (2023). Comprehensive analysis and immunohistochemistry localization of NRP1 expression in pancancer and normal individual tissues in relation to SARS‑CoV‑2 susceptibility. Experimental and Therapeutic Medicine. 27(2). 52–52. 2 indexed citations

Cheng, Jingliang, Ting Li, Jiewen Fu, et al.. (2023). Novel, pathogenic insertion variant of GSDME associates with autosomal dominant hearing loss in a large Chinese pedigree. Journal of Cellular and Molecular Medicine. 28(1). e18004–e18004. 4 indexed citations

Wang, Kai, Jiayue He, Shuguang Liu, et al.. (2022). The Correlation Between Immune Invasion and SARS-COV-2 Entry Protein ADAM17 in Cancer Patients by Bioinformatic Analysis. Frontiers in Immunology. 13. 923516–923516. 15 indexed citations

Cheng, Jingliang, Jiewen Fu, Jiewen Fu, et al.. (2022). The regulation of ISG20 expression on SARS-CoV-2 infection in cancer patients and healthy individuals. Frontiers in Immunology. 13. 958898–958898. 6 indexed citations

10.

Fu, Jiewen, Jiewen Fu, Shuguang Liu, et al.. (2022). Impact of TMPRSS2 Expression, Mutation Prognostics, and Small Molecule (CD, AD, TQ, and TQFL12) Inhibition on Pan-Cancer Tumors and Susceptibility to SARS-CoV-2. Molecules. 27(21). 7413–7413. 9 indexed citations

11.

Zhang, Lianmei, Chunli Wei, Dabing Li, et al.. (2022). COVID-19 receptor and malignant cancers: Association of CTSL expression with susceptibility to SARS-CoV-2. International Journal of Biological Sciences. 18(6). 2362–2371. 23 indexed citations

12.

Fu, Jiewen, Chunli Wei, Jiayue He, et al.. (2021). Evaluation and characterization of HSPA5 (GRP78) expression profiles in normal individuals and cancer patients with COVID-19. International Journal of Biological Sciences. 17(3). 897–910. 32 indexed citations

13.

Cheng, Jingliang, Qi Zhou, Jiewen Fu, et al.. (2021). Novel compound heterozygous missense variants (c.G955A and c.A1822C) of CACNA2D4 likely causing autosomal recessive retinitis pigmentosa in a Chinese patient. 3 Biotech. 11(5). 208–208. 3 indexed citations

14.

Li, Dabing, Xiaoyan Liu, Lianmei Zhang, et al.. (2021). COVID-19 disease and malignant cancers: The impact for the furin gene expression in susceptibility to SARS-CoV-2. International Journal of Biological Sciences. 17(14). 3954–3967. 30 indexed citations

15.

Zhang, Lianmei, Jingliang Cheng, Qi Zhou, et al.. (2020). Targeted Next-Generation Sequencing Identified Novel Compound Heterozygous Variants in the CDH23 Gene Causing Usher Syndrome Type ID in a Chinese Patient. Frontiers in Genetics. 11. 422–422. 13 indexed citations

16.

Duan, Shaofeng, et al.. (2020). Radiomic features of Pk-DCE MRI parameters based on the extensive Tofts model in application of breast cancer. Physical and Engineering Sciences in Medicine. 43(2). 517–524. 15 indexed citations

17.

Fu, Jiewen, Lianmei Zhang, Chunli Wei, et al.. (2020). Expressions and significances of the angiotensin-converting enzyme 2 gene, the receptor of SARS-CoV-2 for COVID-19. Molecular Biology Reports. 47(6). 4383–4392. 142 indexed citations

18.

Zhang, Lianmei, et al.. (2019). Combined application of pharamcokinetic DCE‐MRI and IVIM‐DWI could improve detection efficiency in early diagnosis of ductal carcinoma in situ. Journal of Applied Clinical Medical Physics. 20(7). 142–150. 10 indexed citations

19.

Liu, Xiaoyan, Md. Asaduzzaman Khan, Jingliang Cheng, et al.. (2015). Establishment of stable cell line for inducing KAP1 protein expression. Acta Biologica Hungarica. 66(2). 161–168. 1 indexed citations

20.

Fu, Junjiang, Lianmei Zhang, Tao He, et al.. (2012). TWIST Represses Estrogen Receptor-alpha Expression by Recruiting the NuRD Protein Complex in Breast Cancer Cells. International Journal of Biological Sciences. 8(4). 522–532. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact